GSK3A and Alzheimer disease: In this context, an increase in the phospho-inhibited GSK3α/β isoforms, coincident with a spontaneous accumulation of Aβ peptide in Sgo+/− mouse models that was Wnt pathway activation-dependent, was observed during the late onset of AD [58].